Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death
worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol …

Hepatocellular carcinoma (HCC) is one of the few cancers in which a continued increase in
incidence has been observed over several years. As such, there has been a focus on safe …

Hepatocellular carcinoma (HCC) is the seventh most common cancer worldwide and the
third most common cause of cancer-related deaths; the number of new cases per year is …

Microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is an independent
predictor of poor outcomes subsequent to surgical resection or liver transplantation (LT); …

Background & Aims Treatment with immune checkpoint inhibitors (ICIs) for hepatocellular
carcinoma (HCC) prior to liver transplantation (LT) has been reported; however, ICIs may …

Downstaging can facilitate liver transplantation (LT) for patients outside of Milan criteria with
hepatocellular carcinoma (HCC); however, the optimal protocol and downstaging outcomes …

Increasing evidence suggests that large intervening non-coding RNAs (lincRNAs) regulate
key pathways in cancer invasion and metastasis. In this observational retrospective study …

Hepatocellular carcinoma is a common malignancy for which prevention, screening,
diagnosis, treatment, and surveillance demand a multidisciplinary approach. Knowledge of …

We previously suggested that in patients with heptocellular carcinoma (HCC), the
conventional Milan criteria (T1/T2) for orthotopic liver transplantation (OLT) could be …

Background: Needle biopsy of a suspicious liver lesion could guide management in the
setting of equivocal imaging and serology, although it is not recommended generally …